Torrent Pharmaceuticals has announced a major acquisition of JB Chemicals & Pharmaceuticals for a total equity valuation of ₹25,689 crore. The transaction includes acquiring a **46.39% stake** from KKR for ₹11,917 crore at ₹1,600 per share, followed by an **open offer** for 26% additional shares at ₹1,639.18 per share, and up to 2.80% from employees. The deal will be followed by a **merger**, where JB Pharma shareholders will receive **51 Torrent shares for every 100 JB shares**. This strategic move aims to consolidate Torrent’s position in the Indian pharmaceutical market and expand into untapped areas like ophthalmology and international CDMO operations. Torrent emphasized the synergy benefits, increased market access, and operational efficiencies from the merger. The transaction is subject to regulatory approvals including SEBI, NCLT, and CCI.

TORNTPHARM

JBCHEPHARM

#Post-ClosingCommentary#FundamentalViews#WatchOutFor#StockInNews#TrendingSectors

902 likes·55 comments